Prospective validation of the breast cancer risk prediction model BOADICEA and a batch-mode version BOADICEACentre.
about
Risk determination and prevention of breast cancerPubertal development in girls by breast cancer family history: the LEGACY girls cohort.Breast cancer risks and risk prediction models.Gene-expression patterns in peripheral blood classify familial breast cancer susceptibility.A risk prediction algorithm for ovarian cancer incorporating BRCA1, BRCA2, common alleles and other familial effectsPractical problems with clinical guidelines for breast cancer prevention based on remaining lifetime risk.Breast Cancer Risk Prediction Using Clinical Models and 77 Independent Risk-Associated SNPs for Women Aged Under 50 Years: Australian Breast Cancer Family RegistryiPrevent®: a tailored, web-based, decision support tool for breast cancer risk assessment and management.Cohort Profile: The Breast Cancer Prospective Family Study Cohort (ProF-SC)Breast cancer risk prediction using a polygenic risk score in the familial setting: a prospective study from the Breast Cancer Family Registry and kConFab.BOADICEA breast cancer risk prediction model: updates to cancer incidences, tumour pathology and web interface.Recommendations on breast cancer screening and prevention in the context of implementing risk stratification: impending changes to current policies.Use of the BOADICEA Web Application in clinical practice: appraisals by clinicians from various countries.Testing for Gene-Environment Interactions Using a Prospective Family Cohort Design: Body Mass Index in Early and Later Adulthood and Risk of Breast Cancer.Distribution of breast cancer risk from SNPs and classical risk factors in women of routine screening age in the UK.Risks of breast or ovarian cancer in BRCA1 or BRCA2 predictive test negatives: findings from the EMBRACE study.
P2860
Q26991921-D79E018F-FEF3-4BB7-A8D6-50C15ACD8FF6Q33781466-BE4B5857-89EE-4F25-945A-FBE68B63F492Q35399596-10165F86-C9F7-49CD-B9EB-BD4033093E52Q35832873-B12B6225-F734-418D-951B-776DB60758D0Q35848518-4431BAD2-74CB-47CE-9B64-DE10A6CD7F73Q36009831-17BB7153-CE85-4F63-BFEA-DECA03253E53Q36619329-CCA5F2F8-6126-4745-AAD0-28580CCD835CQ36678510-13E6B5A3-D2CD-459F-AA68-81BD7282E8F7Q37219731-C67CF4AB-761D-431B-8EC6-10ED4A0A4D8DQ37410693-25B2A203-BED7-4ED2-A87A-CE7A72A3B3FEQ37507410-711BAB13-55DA-47E8-9659-EED71C0C6471Q37524981-72C7E4F4-850A-4ECD-B3D9-EF95FE471A13Q38721663-4D7CB452-E787-41D4-A8E6-D2B31B04A2CEQ38842051-A2375E02-80CE-49BF-9B90-D463D359855AQ42587251-AA67D57F-C41D-4E2C-928B-EB55F339690DQ52724999-6A0F77C6-B0AD-4E43-BD0E-649B72775D56
P2860
Prospective validation of the breast cancer risk prediction model BOADICEA and a batch-mode version BOADICEACentre.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prospective validation of the ...... h-mode version BOADICEACentre.
@en
Prospective validation of the ...... h-mode version BOADICEACentre.
@nl
type
label
Prospective validation of the ...... h-mode version BOADICEACentre.
@en
Prospective validation of the ...... h-mode version BOADICEACentre.
@nl
prefLabel
Prospective validation of the ...... h-mode version BOADICEACentre.
@en
Prospective validation of the ...... h-mode version BOADICEACentre.
@nl
P2093
P2860
P50
P356
P1476
Prospective validation of the ...... h-mode version BOADICEACentre.
@en
P2093
A Bickerstaffe
C Apicella
K-A Phillips
R J MacInnis
P2860
P2888
P304
P356
10.1038/BJC.2013.382
P407
P50
P577
2013-08-13T00:00:00Z
P5875
P6179
1008143462